[Justified hope after 4 years. Initial therapy still without resistance].
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D017322:Clinical Trials, Phase II as Topic; D004338:Drug Combinations; D024882:Drug Resistance, Viral / Q000235:genetics; D005500:Follow-Up Studies; D017320:HIV Protease Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D015497:HIV-1 / Q000187:drug effects / Q000235:genetics; D006801:Humans; D008134:Long-Term Care; D061466:Lopinavir; D011744:Pyrimidinones / Q000008:administration & dosage* / Q000009:adverse effects; D019438:Ritonavir / Q000008:administration & dosage* / Q000009:adverse effects
D004338:Drug Combinations; D017320:HIV Protease Inhibitors; D011744:Pyrimidinones; D061466:Lopinavir; D019438:Ritonavir